EUVIMEDEUVIMED entdecken
Crossref

Design and Development of PLGA‐PEG‐FA Nanoparticles Encapsulating Noscapinoids for Receptor‐Mediated Breast Cancer Treatment

Namita Bhoi iD, Pradeep Kumar Naik iD

Drug Development Research · 2026-04 · 87 (2)

DOI: 10.1002/ddr.70278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 05.04.2026. Verfasst von Namita Bhoi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Bioinformatics, Centre of Excellence in Natural Product and Therapeutics, Sambalpur University, Odisha, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Polyethylene Glycols, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Centre of Excellence in Natural Products and Therapeutics (COE-NPT), DST-INSPIRE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Folate‐conjugated PLGA‐PEG nanocarriers have emerged as a promising strategy for targeted delivery of anticancer agents such as 9‐bromo‐noscapine (9‐Br‐Nos) for targeting of folate receptors, which are overexpressed in breast cancer cells. They were synthesized and characterized for their size, morphology, encapsulation efficiency, and drug release profile. In vitro cytotoxicity studies have revealed an enhancement in anticancer efficacy of nano‐formulated drugs compared to free drugs. Enhanced cellular uptake, improved mitochondrial membrane potential, and increased reactive oxygen species (ROS) production were observed in treated cells. Additionally, the spheroid disintegration assay was performed to evaluate the effect of the nano‐formulation on the three‐dimensional (3D) tumor model. Western blot analysis revealed changes in the expression of apoptosis‐related proteins, further supporting the enhanced therapeutic potential of the nanocarrier system. In vivo pharmacokinetic studies demonstrated improvement in bioavailability and prolonged circulation of the nano‐encapsulated drug. This study underscores the potential of nanocarrier‐based drug delivery systems in improving the therapeutic efficacy of anticancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPolyethylene GlycolsNanoparticlesAntineoplastic AgentsNoscapineFolic AcidPolyglactin 910HumansFemaleAnimalsDrug CarriersCell Line, TumorApoptosisDrug LiberationReactive Oxygen SpeciesMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

9‐Br‐NosPLGA‐PEG‐FA nanoparticlesapoptosisbreast cancerreceptor‐mediated endocytosis

Substanzen

Polyethylene GlycolsAntineoplastic AgentsNoscapineFolic AcidDrug Carrierspoly(lactic-glycolic acid)-poly(ethyleneglycol) copolymerReactive Oxygen SpeciesPolyglactin 910

Autor:innen und Institutionen

  • Department of Biotechnology and Bioinformatics, Centre of Excellence in Natural Product and Therapeutics, Sambalpur University, Odisha, India.

ORCID-Profile: Namita Bhoi, Pradeep Kumar Naik

Förderung

  • Centre of Excellence in Natural Products and Therapeutics (COE-NPT)
  • DST-INSPIRE

Zitieren

APA

Bhoi, N., & Naik, P. K. (2026). Design and Development of PLGA‐PEG‐FA Nanoparticles Encapsulating Noscapinoids for Receptor‐Mediated Breast Cancer Treatment. Drug Development Research, 87(2). https://doi.org/10.1002/ddr.70278

Vancouver

Bhoi N, Naik PK. Design and Development of PLGA‐PEG‐FA Nanoparticles Encapsulating Noscapinoids for Receptor‐Mediated Breast Cancer Treatment. Drug Development Research. 2026;87(2). doi:10.1002/ddr.70278

BibTeX
@article{Bhoi2026,
  author = {Bhoi, Namita and Naik, Pradeep Kumar},
  title = {Design and Development of PLGA‐PEG‐FA Nanoparticles Encapsulating Noscapinoids for Receptor‐Mediated Breast Cancer Treatment},
  journal = {Drug Development Research},
  year = {2026},
  volume = {87},
  number = {2},
  doi = {10.1002/ddr.70278}
}
Kostenlos starten →